Dr Jaideep A Gogtay is the Global Chief Medical Officer at Cipla and has been associated with the organization for nearly 25 years now. Jaideep completed his medical graduation (M.B.B.S) from Grant Medical College and Sir J J Group of Hospitals in Mumbai. He then received his M.D degree in Pharmacology from Seth GS Medical College and KEM Hospital. During his post-graduation, he worked as a lecturer of Pharmacology. At Cipla, he has been closely involved in the development and introduction of several drugs in various therapeutic fields, particularly in HIV/AIDS, infectious diseases and respiratory diseases. He has worked on several clinical trials in the field of asthma, COPD and infectious diseases. He was a key member of the team which introduced several antiretroviral drugs for the treatment of AIDS including the 1$ a day triple drug cocktail. Cipla has a large number of anti-infective drugs including antibiotics, anti-viral and anti-fungal which are available in a number of countries. As head of medical affairs, he was responsible for bringing back ‘old’ antibiotics such as Colistin which was reintroduced in India after over 50 years. One of the areas that Cipla continues to work is to update physicians on appropriate use of antibiotics and the current challenges of antimicrobial resistance, both in the community and in the hospital. He was a member of the Association of Physicians of India (Guidelines 2005) on ‘Antiretroviral therapy’. He has 40 publications to his credit including chapters on Pharmacokinetics and Pharmacodynamics of antibiotics and has presented papers at over 50 conferences. He was involved in setting up the Chest Research Foundation (CRF), now an independent research center dedicated to research in the field of respiratory medicine. He is a frequent presence in workshops on research methodology at academic institutions and at several national and international forums.
